chr11-7691982-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_198185.7(OVCH2):c.1427G>A(p.Ser476Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000191 in 1,569,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_198185.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OVCH2 | NM_198185.7 | c.1427G>A | p.Ser476Asn | missense_variant | 13/16 | ENST00000533663.6 | |
LOC105376533 | XR_007062576.1 | n.382C>T | splice_region_variant, non_coding_transcript_exon_variant | 4/11 | |||
OVCH2 | XM_047426878.1 | c.1439G>A | p.Ser480Asn | missense_variant | 13/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OVCH2 | ENST00000533663.6 | c.1427G>A | p.Ser476Asn | missense_variant | 13/16 | 5 | NM_198185.7 | P1 | |
OVCH2 | ENST00000612000.1 | c.1427G>A | p.Ser476Asn | missense_variant | 13/15 | 5 | P1 | ||
OVCH2 | ENST00000673880.1 | c.983G>A | p.Ser328Asn | missense_variant | 9/12 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000769 AC: 14AN: 182160Hom.: 0 AF XY: 0.000114 AC XY: 11AN XY: 96718
GnomAD4 exome AF: 0.0000134 AC: 19AN: 1417514Hom.: 0 Cov.: 30 AF XY: 0.0000171 AC XY: 12AN XY: 700656
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74338
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at